Director, Clinical Pharmacology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Recursion · 21 hours ago

Director, Clinical Pharmacology

Recursion is a clinical stage TechBio company dedicated to improving lives through innovative technologies. They are seeking a Director of Clinical Pharmacology to lead the clinical pharmacology and pharmacometrics strategy for a portfolio of clinical programs in rare diseases and oncology.

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote
Hiring Manager
Daniel Benavides
linkedin

Responsibilities

Develop the clinical pharmacology and pharmacometric strategies to accelerate and support the overall product development plan. You’ll be the Clinical Pharmacology lead for various programs in clinical development, the representative for regulatory interactions, and propose innovative strategies to get therapies to patients faster
Design clinical studies. You’ll provide (clinical) pharmacology input on all clinical study designs, from Phase 1-3 and dedicated Phase 1 clinical pharmacology studies
Author review relevant clinical pharmacology sections for regulatory documents, including Investigator's Brochures (IB), INDs, NDAs, and other regulatory submissions. Act as the clinical pharmacology expert during interactions with health authorities
Interface with cross-functional teams. You’ll work closely with clinical study teams, translational teams (DMPK, Translational Modeling and Toxicology), preclinical teams and due diligence teams to ensure clinical pharmacology-related considerations are addressed
Solve drug development questions/problems by overseeing and/or performing modeling and simulation with various tools to expedite decision making

Qualification

Clinical PharmacologyPharmacokineticsModeling SoftwareRegulatory SubmissionsOncology ExperienceCollaboration SkillsProblem SolvingResults-OrientedEffective Communication

Required

Ph.D. in Pharmaceutical Sciences, Pharmacokinetics or related discipline, M.D with a Clinical Pharmacology expertise, or a Pharm D. with a Clinical Pharmacology fellowship, with 5-9+ years of experience in biotech/pharmaceutical drug development
Demonstrated success leading all clinical pharmacology related aspects of drug development
Ability to work closely with internal and external stakeholders to manage PK, PK-PD, and PK-safety analyses, including non-compartmental analysis, population PK modeling, and PK-PD modeling and simulations to support dose selection, exposure-response and exposure-safety analyses through various phases of drug development
Proficiency with WinNonlin, Monolix, NONMEM, R or other modeling software
Effective skills directed toward driving collaboration, achieving results, influencing, and resolving conflicts across internal and external stakeholders
Demonstrated experience responding to regulatory agency questions, preparing clinical pharmacology aspects of regulatory submissions and attending regulatory meetings
Highly motivated, decisive, and results-oriented individual who is proactive, resourceful, and efficient with the flexibility and creativity to excel in and contribute to a rapidly growing drug discovery and development company

Preferred

Experience in oncology is preferred, but not an absolute requirement

Benefits

Annual bonus
Equity compensation
Comprehensive benefits package

Company

Recursion

company-logo
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.

H1B Sponsorship

Recursion has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)

Funding

Current Stage
Public Company
Total Funding
$865.38M
Key Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M

Leadership Team

leader-logo
Ben Mabey
Chief Technology Officer
linkedin
leader-logo
Imran Haque
SVP, AI and Digital Sciences
linkedin

Recent News

Company data provided by crunchbase